Overview

• The new approach uses an antibody-drug conjugate to target and remove all blood cells marked by CD45.
• Healthy donor stem cells are genetically modified to resist the treatment, ensuring successful transplantation.
• The method aims to replace traditional chemotherapy, reducing side effects and complications.
• Initial studies in animal models and human cells have shown promising results.
• Future clinical trials are planned to further test and optimize the treatment.